Bluesky Explorer

#FUCASO

Latest posts tagged with #FUCASO on Bluesky

Trending

#World Baseball Classic #Rachel Maddow #Trump and Cuba #Vaccine Policy #DLSS 5 #Oscars #Strait of Hormuz #Sonic Racing #Ukraine Conflict #World Baseball Classic #Rachel Maddow #Trump and Cuba #Vaccine Policy #DLSS 5 #Oscars #Strait of Hormuz #Sonic Racing #Ukraine Conflict

Posts tagged #FUCASO

Thiard News@F4F

@newsen.bsky.social

3 months ago

Preview

IASO Biotechnology's Fucaso Therapy Receives BLA Approval for Advanced Multiple Myeloma Treatment IASO Bio's Fucaso therapy, approved by Hong Kong's Department of Health, treats relapsed multiple myeloma. This marks a significant milestone for China-developed therapies.

IASO Biotechnology's Fucaso Therapy Receives BLA Approval for Advanced Multiple Myeloma Treatment #China #Hong_Kong #CAR-T_therapy #IASO_Bio #FUCASO

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

Preview

IASO Bio Showcases Impressive Three-Year Results of CAR-T Therapy for Multiple Myeloma at IMS 2025 IASO Bio revealed notable three-year follow-up findings for its CAR-T therapy, Fucaso, for treating multiple myeloma at the 2025 IMS Annual Meeting, showing strong long-term efficacy.

IASO Bio Showcases Impressive Three-Year Results of CAR-T Therapy for Multiple Myeloma at IMS 2025 #China #Shanghai #CAR-T_therapy #IASO_Bio #FUCASO

2 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

Preview

IASO Bio’s Equecabtagene Autoleucel Secures Regulatory Green Light in Hong Kong IASO Biotherapeutics has received acceptance for its New Drug Application for Equecabtagene Autoleucel, a CAR-T therapy for relapsed multiple myeloma, from Hong Kong health authorities.

IASO Bio’s Equecabtagene Autoleucel Secures Regulatory Green Light in Hong Kong #China #Hong_Kong #CAR-T_therapy #IASO_Bio #FUCASO

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 year ago

Preview

IASO Bio's New Drug Application Acceptance Marks Milestone for FUCASO in Singapore IASO Bio's Equecabtagene Autoleucel (FUCASO) receives NDA acceptance from Singapore's HSA, marking a significant step in CAR-T therapy expansion.

IASO Bio's New Drug Application Acceptance Marks Milestone for FUCASO in Singapore #Singapore #IASO_Bio #Equecabtagene #FUCASO

0 0 0 0